These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
7. Characteristics of the chemotactic response of neoplastic cells to a factor derived from the fifth component of complement. Orr W, Varani J, Ward PA. Am J Pathol; 1978 Nov; 93(2):405-22. PubMed ID: 568888 [Abstract] [Full Text] [Related]
12. Effects of passage, growth phase, and heterogeneity of a tumor cell population on tumor cell chemotaxis. Oda D, Orr FW. Invasion Metastasis; 1984 Jan; 4(4):189-97. PubMed ID: 6533092 [Abstract] [Full Text] [Related]
15. Purification of a human serum protein ("factor E") which enhances cobra venom factor-induced indirect lysis. Identification with the fifth component of complement. Lynen R, Vogt W, Schmidt G, Dieminger L. Z Immunitatsforsch Exp Klin Immunol; 1976 Apr; 151(2):105-16. PubMed ID: 134530 [Abstract] [Full Text] [Related]
16. Chemotactic activity generated from the fifth component of complement by plasma kallikrein of the rabbit. Wiggins RC, Giclas PC, Henson PM. J Exp Med; 1981 Jun 01; 153(6):1391-404. PubMed ID: 6910482 [Abstract] [Full Text] [Related]
18. Cationic proteins of human granulocytes. VI. Effects on the complement system and mediation of chemotactic activity. Venge P, Olsson I. J Immunol; 1975 Dec 01; 115(6):1505-8. PubMed ID: 1184964 [Abstract] [Full Text] [Related]